Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis

Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics

(2014) Oscar G. Vidaurre et al.   BRAIN

Body fluid biomarkers in multiple sclerosis

(2013) Manuel Comabella et al.   LANCET NEUROLOGY

Natalizumab Therapy for Multiple Sclerosis

(2013) Jeremy Chataway et al.   Neurotherapeutics

Fingolimod attenuates ceramide-induced blood–brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes

(2012) Ruben van Doorn et al.   ACTA NEUROPATHOLOGICA

Ceramide Synthase 6 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis

(2012) S. Schiffmann et al.   JOURNAL OF IMMUNOLOGY

Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis

(2012) Francisco J. Quintana et al.   JOURNAL OF NEUROIMMUNOLOGY

CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings

(2012) T. T. Seppala et al.   NEUROLOGY

Identification of Naturally Occurring Fatty Acids of the Myelin Sheath That Resolve Neuroinflammation

(2012) P. P. Ho et al.   Science Translational Medicine

Myelin glycosphingolipid immunoreactivity and CSF levels in multiple sclerosis

(2011) S. Haghighi et al.   ACTA NEUROLOGICA SCANDINAVICA

Analysis of mammalian sphingolipids by liquid chromatography tandem mass spectrometry (LC-MS/MS) and tissue imaging mass spectrometry (TIMS)

(2011) M. Cameron Sullards et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Many Ceramides

(2011) Yusuf A. Hannun et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation

(2011) T. Hla et al.   NEUROLOGY

Chain length-specific properties of ceramides

(2011) Sabine Grösch et al.   PROGRESS IN LIPID RESEARCH

Neurofilament light as a prognostic marker in multiple sclerosis

(2010) Jonatan Salzer et al.   Multiple Sclerosis Journal

Intrathecal increase of sphingosine 1-phosphate at early stage multiple sclerosis

(2010) Alina Kułakowska et al.   NEUROSCIENCE LETTERS

Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?

(2009) M Podbielska et al.   Multiple Sclerosis Journal

The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans

(2008) F. Zohren et al.   BLOOD

A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis

(2008) David Wheeler et al.   BRAIN

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET